SCHEMBL14868017

SCHEMBL14868017

c1ccc(-c2cc(-c3ccc4sc5ccccc5c4c3)cc(-n3c4ccc(-n5c6ccccc6c6ccccc65)cc4c4cc(-n5c6ccccc6c6ccccc65)ccc43)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSPO P30536 1/20 0.36
GPR3 P46089 1/20 0.34
LIMK1 P53667 1/20 0.33
HDAC4 P56524 1/20 0.33
RAC2 P15153 1/20 0.32
RAC3 P60763 1/20 0.32
CDC42 P60953 1/20 0.32
RAC1 P63000 1/20 0.32
CYP1A2 P05177 1/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
DNM1 Q05193 1/20 0.31
PTPN7 P35236 1/20 0.31
DUSP3 P51452 1/20 0.31
PTPN12 Q05209 1/20 0.31
PTPN22 Q9Y2R2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14212277 1.00 PIM3 (0.38) PIM3KDM4EATML3MBTL1TSPO
SCHEMBL17998188 0.99 KDM4E (0.40) PIM3KDM4EATML3MBTL1TSPO
SCHEMBL14867996 0.99 PIM3 (0.37) PIM3KDM4EATML3MBTL1TSPO
SCHEMBL24398147 0.97 KDM4E (0.39) PIM3KDM4EATML3MBTL1TSPO
SCHEMBL14649030 0.97 PIM3 (0.39) PIM3KDM4EATML3MBTL1TSPO
SCHEMBL19980347 0.96 ATM (0.41) PIM3KDM4EATML3MBTL1TSPO
SCHEMBL16641524 0.96 PIM3 (0.36) PIM3KDM4EATML3MBTL1TSPO
SCHEMBL19009387 0.96 ATM (0.40) PIM3KDM4EATML3MBTL1TSPO
SCHEMBL1687716 0.96 ATM (0.40) PIM3KDM4EATML3MBTL1TSPO
SCHEMBL19009379 0.96 ATM (0.40) PIM3KDM4EATML3MBTL1TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895966-B2 Material for organic electroluminescence element, and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2014-11-25 US disclosed
US-8895966-B2 Material for organic electroluminescence element, and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2014-11-25 US disclosed
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-04-18 US disclosed
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME LEF1, ORMDL3, CD99 PIM3 1055/4885KDM4E 1369/4885ATM 2422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.